openPR Logo
Press release

Global Biologics Market Size & Trends

Global Biologics Market Size & Trends

Global Biologics Market Size & Trends

According to a new market research report published by Global Market Estimates, the global biologics market is projected to grow at a CAGR of 10.8% from 2023 to 2028.
The rise in the burden of chronic diseases, the growing prevalence of genetic disorders, and the increasing development of personalized medicine and companion diagnostics are expected to support the market growth during the forecast period.

Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth TOC on "Global Biologics Market - Forecast to 2028''

By Source (Microbial, Mammalian, and Others), By Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense & RNAi Therapeutics, and Others), By Disease (Oncology, Infectious Diseases, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), By Manufacturing (Outsourced and In-house), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

Key Market Insights
• As per the product outlook, the monoclonal antibodies segment is expected to be the largest segment in the global biologics market from 2023 to 2028
• As per the disease outlook, the oncology segment is expected to be the largest segment in the global biologics market from 2023 to 2028
• Asia Pacific is analyzed to be the fastest-growing region in the market
• North America is expected to hold the largest share of the market during the forecast period from 2023-2028
• Samsung Biologics, Amgen Inc., Novo Nordisk A/S, AbbVie Inc., Sanofi, Johnson & Johnson Services, Inc., Celltrion Healthcare Co., Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, and F. Hoffmann La-Roche Ltd. among others, are some of the key players in the global biologics market

Source Outlook (Revenue, USD Billion, 2023-2028)
• Microbial
• Mammalian
• Others

Product Outlook (Revenue, USD Billion, 2023-2028)
• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Antisense & RNAi Therapeutics
• Others

Disease Outlook (Revenue, USD Billion, 2023-2028)
• Oncology
• Infectious Diseases
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others

Manufacturing Outlook (Revenue, USD Billion, 2023-2028)
• Outsourced
• In-house

By Regional Outlook (Revenue, USD Billion, 2023-2028)
North America
• U.S.
• Canada
• Mexico
• Germany
• U.K.
• France
• Spain
• Italy
• Netherlands
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Thailand
• Indonesia
• Malaysia
• Singapore
• Vietnam
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Chile
• Rest of CSA
Middle East and Africa
• Saudi Arabia
• Israel
• South Africa
• Rest of MEA

Contact: Yash Jain
Director- Global Accounts & Strategic Advisory
Email address:
Phone Number: +1 6026667238

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biologics Market Size & Trends here

News-ID: 3217423 • Views: 181

More Releases for Biologics

Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report. the
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off) The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025. Get Free Sample Copy of this Research
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to